0001104659-23-073743.txt : 20230622 0001104659-23-073743.hdr.sgml : 20230622 20230622160640 ACCESSION NUMBER: 0001104659-23-073743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230620 FILED AS OF DATE: 20230622 DATE AS OF CHANGE: 20230622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hambleton Julie CENTRAL INDEX KEY: 0001578771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 231033386 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm2319378-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-20 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001578771 Hambleton Julie C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 1 0 0 0 1 Common Stock 2023-06-20 4 S 0 2400 26.9180 D 7066 D The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 17, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.44 to $27.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Francis I. Perier, Jr. as Attorney-in Fact 2023-06-22